Benign and malignant plasma cell dyscrasias: methods of study
Geniram, A.; Fiorini, G.; Spotti, D.; Frezzini, G.; Guarino, P.; Venturino, M.; Marini, U.
Haematologica 69(2): 163-177
1984
ISSN/ISBN: 0390-6078 PMID: 6203816 Document Number: 239204
Document emailed within 1 workday
Related Documents
Karmakar, T.; Datta, U.; Varma, S.; Banerjee, C.K.; Sharma, S.; Sehgal, S. 1995: Paraproteins and plasma cell dyscrasias Indian Journal of Pathology and Microbiology 38(3): 239-243Eichner, E.R. 1980: The plasma cell dyscrasias: diverse presentations, pathophysiology, and management Postgraduate Medicine 67(6): 44-9 53-4 57-8 Passim
Avisar, R.; Shoenfeld, Y.; Pick, A.I.; Creter, D.; Cohen, A.; Djaldetti, M.; Savir, H. 1981: Plasma cell dyscrasias. Part I: Fluorescein angiography findings Metabolic and Pediatric Ophthalmology 5(3-4): 171-175
Greco, C.; Alvino, S.; Del Monte, G.; Venturo, I.; Lopez, M. 2003: Potential usefulness of serum p53 for laboratory management of plasma cell dyscrasias Journal of Experimental and Clinical Cancer Research: Cr 22(4): 607-612
Zelichowski, G.; Raczka, A.; Sułek, K.; Wańkowicz, Z. 2000: Evaluation of nephrologic "risk" in a newly diagnosed case of plasma cell dyscrasias from personal material (1994-2000) Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 9(54): 830-833
Lenert, P.; Drazen, F.; Tepavcević, P.; Pejin, D.; Curić, S.; Ilić, V.; Uzurov, V.; Popowić, S.; Zupunski, A.; Djisalov, M. 1985: Influence of Bence-Jones proteins, hyperviscosity, hypercalcemia, hyperuricemia and dehydration on development of renal changes in plasma cell dyscrasias Przeglad Lekarski 42(4): 384-386
Szczepulska-Wójcik, E.; Langfort, R.; Roszkowski-Sliz, K. 2007: A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation Pneumonologia i Alergologia Polska 75(1): 57-69
Cooper, M.R.; Toole, J.F. 1972: Sickle-cell trait: benign or malignant? Annals of Internal Medicine 77(6): 997-998
Thoenes, W.; Störkel, S. 1991: Pathology of benign and malignant renal cell tumors Der Urologe. Ausg. a 30(6): W41-W50
Vitali, C.; Ferri, C.; Nasti, P.; La Civita, L.; Mazzantini, M.; Longombardo, G.; Bombardieri, S. 1994: Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia British Journal of Rheumatology 33(8): 791-792
Barnard, S.; Leen, E.; Cooke, T.; Angerson, W. 2008: A contrast-enhanced ultrasound study of benign and malignant breast tissue South African Medical Journal 98(5): 386-391
Kamei, I.; Yoshida, N.; Yukawa, S.; Yabumoto, M.; Iwamoto, M.; Kuriyama, T.; Yokoyama, M.; Shizuki, K. 1992: Malignant transformation of benign mixed tumor of lacrimal gland to squamous cell carcinoma 19 years after initial surgery: report of a case No Shinkei Geka. Neurological Surgery 20(1): 79-83
Kotańska, K.M.; Holm, R.; Ottestad, L.; Nesland, J.M. 1989: An ultrastructural study of benign and malignant breast epithelial cells. A search for tonofilaments Journal of Submicroscopic Cytology and Pathology 21(3): 469-474
Bandaletova, T.I. 1991: The immunohistochemical study of lymphocyte subpopulations in benign and malignant epithelial tumors of the large intestine Voprosy Onkologii 37(2): 193-196
Mazur, M.T.; Shultz, J.J.; Myers, J.L. 1990: Granular cell tumor. Immunohistochemical analysis of 21 benign tumors and one malignant tumor Archives of Pathology and Laboratory Medicine 114(7): 692-696
Kornstein, M.J.; deBlois, G.G.; Williams, M.E. 1992: Unusual biclonal plasma cell dyscrasia with crystallike inclusions producing colonic tumors (plasma cell polyposis) and terminating in T-cell lymphoma Archives of Pathology and Laboratory Medicine 116(2): 168-172
Katiyar, S.K.; Agarwal, R.; Mukhtar, H. 1993: Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea Cancer Research 53(22): 5409-5412
Peschos, D.; Tsanou, E.; Stefanou, D.; Damala, C.; Vougiouklakis, T.; Mitselou, A.; Agnantis, N.J. 2004: Expression of cyclin-dependent kinases inhibitors p21(WAF1) and p27(KIP1) in benign, premalignant and malignant laryngeal lesions. correlation with cell cycle regulatory proteins In Vivo 18(6): 719-724
Howard, J.M.; Gohara, A.F.; Cardwell, R.J. 1989: Malignant islet cell tumor of the pancreas associated with high plasma calcitonin and somatostatin levels Surgery 105(2 Part 1): 227-229
Hennings, H. 1989: Malignant conversion: the first stage in progression from benign to malignant tumors Progress in Clinical and Biological Research 298: 95-100